For the Inventor, By the Inventor

Enter assignee name

Irvine, CA, United States of America

Chromadex Inc.

USPTO Granted Patents = 23

EPO Patents = 5

Trademarks = 14

Forward Citations = 54

Loading Chart...

Loading Chart...

27 inventors (with patents filed for the assignee):

Marie Eugenie Migaud (12 out of 19 patents)

Aron Erickson (11 out of 11 patents)

Philip Redpath (10 out of 15 patents)

4. Kerri Crossey (10 out of 15 patents)

5. Richard Cunningham (10 out of 10 patents)

6. Troy Rhonemus (10 out of 10 patents)

7. Ryan Dellinger (9 out of 18 patents)

8. Amanda Storjohann (9 out of 9 patents)

9. Richard Nygaard (7 out of 10 patents)

10. Mark Morris (4 out of 12 patents)

11. Philip Redpath (4 out of 4 patents)

12. Amy Boileau (3 out of 3 patents)

13. Dietrich Conze (3 out of 3 patents)

14. Ann Deren-Lewis (2 out of 2 patents)

15. Sylesh Venkataraman (2 out of 2 patents)

23 patents: Sort by Forward Citations

1. 12760055 - Methods of preparing reduced nicotinamide riboside and derivatives thereof (2026-10-13),

2. 12558367 - Nicotinamide riboside and derivatives thereof in intravenous formulations and methods of use thereof (2026-02-24),

3. 12485134 - Use of nicotinamide riboside, nicotinic acid riboside, reduced nicotinyl riboside compounds, and nicotinyl riboside compound derivatives in formulations (2025-12-02),

4. 12433908 - Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development (2025-10-07),

5. 12195494 - Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof (2025-01-14),

6. 11746123 - Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof (2023-09-05),

7. 11524022 - Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development (2022-12-13),

8. 11345720 - Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof (2022-05-31),

9. 11274117 - Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof (2022-03-15),

10. 11242364 - Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof (2022-02-08),

11. 11214589 - Crystalline forms of nicotinoyl ribosides and derivatives thereof, and methods of preparation thereof (2022-01-04),

12. 11033568 - Nicotinamide riboside compositions for topical use in treating skin conditions (2021-06-15),

13. 10934322 - B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof (2021-03-02),

14. 10857172 - Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development (2020-12-08),

15. 10689411 - Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof (2020-06-23),

Company Overview

Chromadex Inc. is a biotechnology company based in Irvine, California, specializing in the development and commercialization of innovative nutritional products and ingredients. The company focuses on research and technology related to health and wellness, particularly in the areas of dietary supplements and natural products. Chromadex is dedicated to advancing scientific knowledge and providing solutions that enhance human health through its proprietary compounds and formulations.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

23 Patents

#145 in Irvine, CA

#3,419 in California

#14,428 in US

#27,685 in the World

Irvine, CA, United States of America

Chromadex Inc.

Forward Citations = 54

27 inventors:

Marie Eugenie Migaud (12 out of 19 patents)

Aron Erickson (11 out of 11 patents)

Philip Redpath (10 out of 15 patents)

4. Kerri Crossey (10 out of 15 patents)

5. Richard Cunningham (10 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Chromadex Inc.. Retrieved from https://idiyas.com/company/chromadex

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…